Clonidine-catecholamine suppression test
Indication |
|
Contraindication | Bradycardia, hypovolemia, hypotension, current treatment with beta-blockers |
Principle | Clonidine is an alpha-adrenergic agonist, which centrally attacks and suppresses especially noradrenalin, and to a lesser degree adrenalin. In case of pheochromocytoma, the increase of catecholamines is caused by autonomous secretion, which cannot be suppressed by clonidine administration. |
Evaluation parameters | Adrenalin, noradrenalin, blood pressure monitoring |
Material | 3 ml EDTA-blood has to be centrifuged straight away, the plasma transferred into a special tube for catecholamine evaluation (+ glutathione) and frozen immediately. Blood collection before and 3 hours after clonidine administration. Mark tubes with extraction timings. A freezing container will be issued on request. During the test, blood pressure and pulse should be checked every 30 min. |
Procedure | The following medication should be discontinued 7 days before test start: Tricyclic antidepressants, phenoxybenzamine, doxazosin, MAO-inhibitors, paracetamol, levodopa and beta-blockers. Apart from calcium-antagonists, any other antihypertensive therapy has to be paused at least 24 hours prior to test start.
Side effects |
Evaluation | After clonidine administration, the plasma-catecholamines should fall to normal values or decrease by at least 40% of the original value. |
More Results for the letter C
- Calcitonin stimulation test
- Pentagastrin-test
- Calcium stimulation test on suspicion of C-cell carcinoma
- Captopril test
- Clonidine-catecholamine suppression test
- Combined stimulation test of the anterior lobe of the pituitary gland
- Pituitary gland stimulation test
- Cortisol day profile
- CRH stimulation test
- Corticotropin-releasing-hormone-test